Where Technology meets Opportunity in Science and Engineering
Power At your Finger Tips
Maxims of Tech: Rules of Engagement for a Fast Changing Environment
Click category or weSRCH domain below to read news from each weSRCH domain
High Tech :- Business, Consumer, Displays, IT, Mobile, Photo, Semiconductors
Medicine :- Biology, Biotech/Pharma, Equipment, Imaging, Implants, Practice Mngmnt, Therapy, Veterinary
Green Tech :- Battery & Fuel, Biomass, Environmental, Fossil/Nuclear, Lighting, Solar, Trans, Wind/Water/Geo
Business :- Companies, Entrepreneurial, IP/Law, Leadership & Strategy, Management, Sales & Marketing, Social Innovation

Latest News, Top News, Breaking News

    Total record(s) 1689 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>

    JCR Pharmaceuticals Co., Ltd. - Pipeline Review, Market Growth, Segment, Trends and Forecast 2016 - 2020 - Medgadget.com (blog)

      MRS109 "JCR Pharmaceuticals Co., Ltd. Global 2015 Clinical Trials Review, H2? provides an detailed overview of JCR Pharmaceuticals Co., Ltd. scenario. Report includes top li ....more | Save |  Share  Email 6th Feb 2016 

    Why Ionis Pharmaceuticals Inc Plunged 36% in January - Motley Fool

      Motley Fool The Motley Fool owns shares of and recommends Ionis Pharmaceuticals. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse rang ....more | Save |  Share  Email 6th Feb 2016 

    LETTER: Same sex marriage damages many aspects of society - Shelby Township Source Newspapers

      Shelby Township Source Newspapers ... nonsense that literally only you believe. In reality SSM is legal. Surrogacy is not going anywhere and fertility treatment will continue to advance. There may even come a d ....more | Save |  Share  Email 6th Feb 2016 

    The Silly Reason Why Agios Pharmaceuticals Inc. Was Clobbered in January - Motley Fool

      Motley Fool What: Shares of Agios Pharmaceuticals (NASDAQ:AGIO), a clinical-stage drug developer primarily focused on researching cancer and rare-disease treatments, were hammered in January, falling 35% based on data ....more | Save |  Share  Email 6th Feb 2016 

    'Mad Money' Lightning Round: Expect More Pain From Regeneron Pharmaceuticals - TheStreet.com

      TheStreet.com Regeneron Pharmaceuticals (REGN - Get Report) : "This is a high-multiple stock that will come back in favor eventually, but in the short term expect more pain." Exclusive Look Ins ....more | Save |  Share  Email 6th Feb 2016 

    Visible signs that diabetes is treatable - Buffalo News

      Buffalo News "We have been able to show a reversal of complications and we have not had a single amputation in our patients in the 20 years that we have existed.? - Dr. Ajay Chaudhuri, medical director of the Diabetes and Endocrinology Center of ....more | Save |  Share  Email 6th Feb 2016 

    Molecular Diagnostics Market (2015 to 2021) - The report provides in-depth analysis of parent market trends, macro ... - Medgadget.com (blog)

      In addition, molecular diagnostic kits are used in pharmacogenetics testing and blood donor screening. North America dominates the global market of molecular dia ....more | Save |  Share  Email 5th Feb 2016 

    Calm Seas Capital Llc Just Opened Huge Vistagen Therapeutics, Inc Position - fdanewsalert.com

      Its CardioSafe 3D bioassay system uses human pluripotent stem cell (hPSC)-derived cardiomyocytes. Its LiverSafe 3D bioassay system uses hPSC-derived hepatocytes (liver cells), to predict potential liver toxici ....more | Save |  Share  Email 5th Feb 2016 

    Diabetes can't stop Flower Mound top recruit - WFAA.com

      WFAA.com "It's probably been four games -- three or four games I haven't been able to start because I've had low blood sugar," says Lauren Cox, a senior post for Flower Mound high school. Lauren has type 1 diabe ....more | Save |  Share  Email 5th Feb 2016 

    New Stanford President Has Biotech Connection - New York Times

      Xconomy Stanford benefits greatly from its relationships in Silicon Valley and also in the biotech industry, a field in which, in addition to his executive role at Genentech, Dr. Tessier-Lavigne has been involved, at several start ....more | Save |  Share  Email 5th Feb 2016 

    Local boy seeking service dog for Type 1 diabetes control - The Bakersfield Californian

      Many boys enjoy the company of dogs, but in Elijah Lidgett's case a pooch could mean not just a best friend but a potential lifesaver. Elijah, 9, has Type 1 diabetes. His blood sugar can spike or drop quickly, s ....more | Save |  Share  Email 5th Feb 2016 

    Shifting Paradigm in Diabetes Treatment - An Interview with Dr. Vinik - Diabetes In Control

      How SGLT-2 inhibitors can provide new approach over treatment centered on attaining glycemic control, intensive therapy. What has been taught in school and reinforced in our minds about diabetes care is to attai ....more | Save |  Share  Email 5th Feb 2016 

    D2 - Dementia and Diabetes - Diabetes In Control

      Diabetes In Control Dementia may strike individuals with inadequately managed diabetes, high blood pressure, high cholesterol and heart disease even harder, as these ailments increase the risk for 'vascular dementia'-caused by a series of small st ....more | Save |  Share  Email 5th Feb 2016 

    AACE/ACE 2016 Update on Standards of Medical Care in Diabetes - Diabetes In Control

      Diabetes In Control The American Association of Clinical Endocrinologists (AACE), in conjunction with the American College of Endocrinology (ACE), has published updates for the Comprehensive Diabetes Management Algorithm ....more | Save |  Share  Email 5th Feb 2016 

    IMPORTANT TETRAPHASE PHARMACEUTICALS SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz ... - GlobeNewswire (press release)

      NEW YORK, Feb. 05, 2016 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed against Tetraphase Pharmac ....more | Save |  Share  Email 5th Feb 2016 

    The Key Takeaways From Alexion Pharmaceuticals Inc.'s Earnings Release - Motley Fool

      Motley Fool Biotech heavyweight Alexion Pharmaceuticals (NASDAQ:ALXN) released its fourth-quarter 2015 earnings results before the opening bell Wednesday. Like many other biotechs, Alexion's shares have taken a ....more | Save |  Share  Email 5th Feb 2016 

    BioTime Inc (BTX) Hits New 52-week Low During February 05 Session - Equities.com

      The Company is engaged in the biomedical research and product development in regenerative medicine including human embryonic stem cell and induced pluripotent stem cell technology. BioTime Inc has 120 employees, is led by ....more | Save |  Share  Email 5th Feb 2016 

    3 Things to Look for in Regeneron Pharmaceuticals Inc.'s Earnings - Motley Fool

      Motley Fool It's been a rough couple of months to be an investor in Regeneron Pharmaceuticals (NASDAQ:REGN). While the company itself continues to fire on all cylinders and looks to have an exciting year ahead, the m ....more | Save |  Share  Email 5th Feb 2016 

    How diabetes diagnosis will close my Candy Drawer: Rich Archbold - Long Beach Press Telegram

      I said. Diabetes? How can that be. I've always been pretty healthy, maybe a little overweight, well, OK, maybe a lot overweight. I have since found out that there are five stages people go through when they ....more | Save |  Share  Email 5th Feb 2016 

    This Biotech Company Is Growing Meatballs in a Lab - Smithsonian

      Smithsonian For the last few years, several biotech companies have been vying to be the first to bring lab-grown meat to supermarket shelves. Now, San Francisco-based startup Memphis Meats is moving ahead in the race by unveiling its first ....more | Save |  Share  Email 5th Feb 2016 
    Total record(s) 1689 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>